Related Experiment Videos
Physiologic and pharmacologic factors that affect myocardial relaxation
L Vittone1, C Mundiña-Weilenmann, A Mattiazzi
1Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Argentina.
Journal of Pharmacological and Toxicological Methods
|September 1, 1994
Summary
Assessing heart relaxation is crucial for treating heart failure. This review covers cellular mechanisms and drug effects on myocardial relaxation, aiding therapeutic strategies.
Area of Science:
- Cardiology
- Pharmacology
- Molecular Biology
Background:
- Myocardial relaxation is vital for cardiac function and can precede contractile dysfunction.
- Impaired myocardial relaxation (lusitropism) is a significant factor in heart failure development.
- Understanding cellular mechanisms of relaxation is key for effective therapeutic interventions.
Purpose of the Study:
- To review current knowledge on myocardial relaxation.
- To discuss how drugs impact cellular mechanisms of relaxation.
- To evaluate mechanical parameters for assessing lusitropism in pharmacological research.
Main Methods:
- Literature review of scientific articles.
- Analysis of cellular mechanisms: sarcoplasmic reticulum function, calcium (Ca2+) fluxes, and myofilament Ca2+ sensitivity.
- Discussion of mechanical parameters in experimental models.
Main Results:
- Impaired lusitropism is an early indicator of cardiac dysfunction.
- Drug effects on cellular targets influence myocardial relaxation.
- Specific mechanical parameters are useful for evaluating lusitropic state in research.
Conclusions:
- Accurate assessment of myocardial relaxation is essential for managing heart failure.
- Targeting cellular mechanisms of relaxation offers therapeutic potential.
- Standardized evaluation of lusitropism in experimental models is important for drug development.